TO EVALUATE THE EFFICIENCY AND SAFETY OF PRUTNYAK IN THE TREATMENT OF HYPERPROLACTINEMIA

Authors

  • Oltieva Malohat Scientific and advisory polyclinic "Family and Marriage" RSNPMC of Obstetrics and Gynecology of the Republic of Uzbekistan

Abstract

Hyperprolactinemia (HPRL) has a significant impact on the health and quality of life of patients. As a result, patients often stop taking medications, which worsens the prognosis of the disease. Thus, managing HPPD during treatment has become a challenge for clinicians.

Downloads

Published

2022-10-21

Issue

2022: SGCES-AUSTRIA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

TO EVALUATE THE EFFICIENCY AND SAFETY OF PRUTNYAK IN THE TREATMENT OF HYPERPROLACTINEMIA. (2022). Archive of Conferences, 171-172. https://conferencepublication.com/index.php/aoc/article/view/2204